welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
- log in
The Power of Purposeful Thinking
It’s Not the End of The World
Research Survey About Impacts of COVID-19
The Calling of a Caregiver
The Secret to Discovering Life’s Greatest Moments
Duchenne Muscular Dystrophy Research TermsCureDuchenne
Exon Skipping and Stop Codon Read-ThroughDuchenne UK
What are the TREAT-NMD Global Registries?Treat-NMD
Duchenne Muscular Dystrophy – A Guide for Patients and FamiliesMuscular Dystrophy Association
Coronavirus Health Update Guide by CureDuchenneCureDuchenne
Safety and Effectiveness of Ataluren: Comparison of Results From the STRIDE Registry and CINRG DMD Natural History StudyJournal of Comparative Effectiveness Research
Life Expectancy at Birth in Duchenne Muscular Dystrophy: A Systematic Review and Meta-AnalysisEuropean Journal of Epidemiology
Is it the Right Time for an Infant Screening for Duchenne Muscular Dystrophy?Neurological Sciences
Enhanced CRISPR-Cas9 Correction of Duchenne Muscular Dystrophy in Mice by a Self-Complementary AAV Delivery SystemScience Advances
Recombinant Human Insulin-Like Growth Factor-1 Therapy for 6 Months Improves Growth but not Motor Function in Boys With Duchenne Muscular DystrophyMuscle & Nerve
Clinical Development on the Frontier: Gene Therapy for Duchenne Muscular DystrophyExpert Opinion on Biological Therapy
The Management of Skeletal Health in Boys With Duchenne Muscular DystrophyScottish Muscle Network
Duchenne Muscular Dystrophy Scottish Physiotherapy Management ProfileScottish Muscle Network Physiotherapy Group
Caregiver Considerations for Duchenne Muscular DystrophyPTC Therapeutics, Inc.
Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice RecommendationsJournal of Neuromuscular Diseases
Durable Medical Equipment (DME) GuideCureDuchenne
Evaluating implementation of the updated care considerations for Duchenne muscular dystrophyPediatrics
Care Considerations for Duchenne Muscular Dystrophy were published in 2010. However, little is known about the extent to which these considerations were implemented after publication. With this article, we provide direction on evaluating the uptake of the 2018 Duchenne Muscular Dystrophy Care Considerations. We identify key elements of care and present suggestions for their use in evaluation and research.
DMD clinical therapies II: P.135 DMD-HUB: expanding clinical trial capacity for Duchenne muscular dystrophy, 1 year onNeuromuscular Disorders
DMD clinical therapies II: P.133 The burden of participation in a clinical trial for boys with Duchenne muscular dystrophyNeuromuscular Disorders
New therapeutic approaches: I.9 Treatment of Duchenne muscular dystrophy: current efforts, bottlenecks and future prospectsNeuromuscular Disorders
Exhaustive characterization of the newly developed Duchenne muscular dystrophy rat model: a unique animal model for DMD which mimics the human disease at both the muscular and the cardiac levelsNeuromuscular Disorders
Finding clinical meaning in patient-reported functional health: development of the Duchenne muscular dystrophy lifetime mobility scaleNeuromuscular Disorders
The 100-meter timed test: ability to detect change over time in Duchenne muscular dystrophyNeuromuscular Disorders
An Interview With Eric OlsonDevelopment | The Company of Biologists
CureDuchenne Professional CourseCureDuchenne
An Introduction to the Duchenne Muscular DystrophyStatPearls Publishing LLC
Understanding Neuromuscular Disease CareIQVIA Institute Report
eDystrophin : A Database Dedicated to Human Dystrophin VariantsEDystrophin
eDystrophin is a database dedicated to human dystrophin variants produced by in-frame DMD gene mutations. This website takes you from the GENE to the PROTEINS through structural investigation and visualization. It is a locus specific database for in-frame mutations and single-nucleotide polymorphism (SNPs) found in the DMD gene and the associated dystrophin variants.